Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 1321 AL 1335

[Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)]

Johannesson T, Kristinsson J, Torsdottir G, Snaedal J.

Laeknabladid. 2012 Oct;98(10):531-7. doi: 10.17992/lbl.2012.10.457.

A novel PSEN1 H163P mutation in a patient with early-onset Alzheimer's disease: clinical, neuroimaging, and neuropathological findings

Kim J, Bagyinszky E, Chang YH, Choe G, Choi BO, An SS, Kim S.

Neurosci Lett. 2012 Nov 21;530(2):109-14. doi: 10.1016/j.neulet.2012.09.040. Epub 2012 Oct 6.

Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease

Rana AQ, Vaid HM, Edun A, Dogu O, Rana MA.

J Neurol Sci. 2012 Dec 15;323(1-2):158-61. doi: 10.1016/j.jns.2012.09.007. Epub 2012 Oct 9.

Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome

Cárdenas AM, Ardiles AO, Barraza N, Baéz-Matus X, Caviedes P.

Arch Med Res. 2012 Nov;43(8):645-54. doi: 10.1016/j.arcmed.2012.10.012. Epub 2012 Nov 7.

Caregiver burden in Parkinson disease with dementia compared to Alzheimer disease in Korea

Shin H, Youn J, Kim JS, Lee JY, Cho JW.

J Geriatr Psychiatry Neurol. 2012 Dec;25(4):222-6. doi: 10.1177/0891988712464819. Epub 2012 Nov 21.

[Guideline-based diagnosis of dementia etiology]

Hofmann W.

Z Gerontol Geriatr. 2012 Dec;45(8):761-71; quiz 772-3. doi: 10.1007/s00391-012-0399-y.

Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex

Marras C, Herrmann N, Anderson GM, Fischer HD, Wang X, Rochon PA.

Am J Geriatr Pharmacother. 2012 Dec;10(6):381-9. doi: 10.1016/j.amjopharm.2012.11.001.

Different approaches, one target: understanding cellular mechanisms of Parkinson's and Alzheimer's diseases

Torrão AS, Café-Mendes CC, Real CC, Hernandes MS, Ferreira AF, Santos TO, Chaves-Kirsten GP, Mazucanti CH, Ferro ES, Scavone C, Britto LR.

Braz J Psychiatry. 2012 Oct;34 Suppl 2:S194-205. doi: 10.1016/j.rbp.2012.08.004.

Frontotemporal dementia: implications for understanding Alzheimer disease

Goedert M, Ghetti B, Spillantini MG.

Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006254. doi: 10.1101/cshperspect.a006254.

Creutzfeldt-Jakob disease with the M232R mutation in the prion protein gene in two cases showing different disease courses: a clinicopathological study

Takeda N, Yokota O, Terada S, Haraguchi T, Nobukuni K, Mizuki R, Honda H, Yoshida H, Kishimoto Y, Oshima E, Ishizu H, Satoh K, Kitamoto T, Ihara Y, Uchitomi Y.

J Neurol Sci. 2012 Jan 15;312(1-2):108-16. doi: 10.1016/j.jns.2011.08.008. Epub 2011 Oct 7.

Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke

Iwamoto J, Takeda T, Matsumoto H.

Acta Neurol Scand. 2012 Apr;125(4):279-84. doi: 10.1111/j.1600-0404.2011.01555.x. Epub 2011 Jun 18.

Steroid-responsive encephalopathy subsequently associated with Alzheimer's disease pathology: a case series

Mateen FJ, Josephs KA, Parisi JE, Drubach DA, Caselli RJ, Kantarci K, Jack C Jr, Boeve BF.

Neurocase. 2012 Feb;18(1):1-12. doi: 10.1080/13554794.2010.547503. Epub 2011 Jun 30.

Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system

Montgomery SL, Bowers WJ.

J Neuroimmune Pharmacol. 2012 Mar;7(1):42-59. doi: 10.1007/s11481-011-9287-2. Epub 2011 Jul 5.

A mitochondrial etiology of Alzheimer and Parkinson disease

Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, Laferla F, Wallace DC.

Biochim Biophys Acta. 2012 May;1820(5):553-64. doi: 10.1016/j.bbagen.2011.08.008. Epub 2011 Aug 16.

Neuroprotection in metabolism-based therapy

Hartman AL.

Epilepsy Res. 2012 Jul;100(3):286-94. doi: 10.1016/j.eplepsyres.2011.04.016. Epub 2011 Aug 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias